You may have to register before you can download all our books and magazines, click the sign up button below to create a free account.
An overview of all the available literature on the various aspects of the regulation of the cardiovascular system`s function and physiology by the adrenergic neurohormonal system, i.e. the catecholamines norepinephrine and epinephrine. Although there are several books describing the adrenergic system`s biology, physiology and pharmacology, and also several excellent books on cardiovascular physiology and pathology, this book focuses exclusively on the interface of these two areas: cardiovascular regulation by the adrenergic system and how it affects cardiovascular diseases and their treatments. Each chapter describe the roles of the adrenergic system first in each cardiovascular cell type (c...
Alzheimer’s disease (AD) is an age-related neurological disease that affects tens of millions of people, in addition to their carers. Hallmark features of AD include plaques composed of amyloid beta, as well as neurofibrillary tangles of tau protein. However, despite more than a century of study, the cause of Alzheimer’s disease remains unresolved. The roles of amyloid beta and tau are being questioned and other causes of AD are now under consideration. The contributions of researchers, model organisms, and various hypotheses will be examined in this Special Issue.
This book focuses specifically on the management of cardiovascular disease in elderly patients with particular frailties and in the “oldest old”. It is clearly explained how treatment in these patients differs from that in patients in their seventies who respond well to therapies and do not present frailties or organ failures. Although not young, the latter patients can be treated almost like any other patient, according to established guidelines. In contrast, the frail, compromised elderly and the oldest old require specific measures that target their needs, including with respect to underlying renal conditions. The book considers all those pathologies that have a high prevalence in the general population, explaining advanced treatment concepts and all aspects of assessment. Key clinical points are highlighted, and the text is supplemented with numerous informative figures and tables. The authors are respected experts, for the most part geriatric physicians, and the book is especially addressed to cardiologists, who may lack the described targeted information and treatment tools.
According to the most updated epidemiological studies, cardiovascular disease remains a leading cause of death; in fact, despite substantial advances in the care of patients, the incidence of cardiovascular disorders continues to increase. Therefore, the search for novel mechanisms and therapeutics is desperately needed, and translational studies represent the best strategy to uncover novel therapeutic targets, reduce mortality, and improve the quality of life. This book gathers original articles and systematic reviews that have both a strong basic research background and clear translational potential. All the studies have been peer reviewed by at least two experts in the field. These contributions provide an updated systematic overview that examines, in detail, the mechanisms of the main cardiovascular and metabolic disorders, including ischemic and non-ischemic heart failure, hypertension, thromboembolism, atherosclerosis, stroke, diabetes mellitus, dyslipidemia, metabolic syndrome, valvulopathies, peripheral artery disease. In the final chapter, the functional role of the endothelium in the systemic manifestations of COVID-19 is described.
This volume offers a comprehensive and up-to-date overview of the major surgical procedures performed on elderly patients. With advancing age the conditions that require surgery normally increase in incidence, and today all surgeons around the globe can be considered “geriatric surgeons”. The latest anesthesiological procedures, the technical improvements and an increased medical knowledge of the comorbities impact have brought extraordinary advances in this field, but this should not allow us to forget that a careful assessment of elderly patients is necessary before undertaking surgery, since also the simplest surgical procedures could alter the delicate psychophysical equilibrium of these “frail” patients. Introduced by a demographic panorama and analysis, the book describes the anesthesiological management, the preoperative assessment and preparation, the perioperative care, and hemostasis control connected with the main surgical pathologies: gastrointestinal, endocrine, neoplastic, vascular and hepato-biliary, as well with traumatic and non-traumatic emergencies. It will be an invaluable, easy-to-use resource for clinicians, researchers and trainees alike.
Aldosterone, Volume 109, the latest release in the Vitamins and Hormones series first published in 1943, covers the field of hormone action, vitamin action, X-ray crystal structure, physiology and enzyme mechanisms, with this release focusing on topics relating to Aldosterone Research, Aldosterone and Micrornas, the Evolution of the Mineralocorticoid Receptor, Aldosterone and Kidney Micrornas, Adipocyte Mineralocorticoid Receptor, Regulation of Aldosterone Secretion, Leptin and Aldosterone, Cell- and Ligand-Specific Interactions in Mineralocorticoid Receptor Signaling, Primary Aldosteronism, Present and Future, Aldosterone-Producing Adenomas, Overexpression of the Mineralocorticoid Receptor, Aldosterone and Myocardial Pathology, and much more. - Focuses on the newest aspects of hormone action in connection with diseases, with this update focusing on aldosterone - Lays the groundwork for the focus of new chemotherapeutic targets - Represents reviews on emerging areas in hormone action, cellular regulators and signaling pathways
description not available right now.
This issue of Heart Failure Clinics, Guest Edited by Dr. Pasquale Perrone Filardi, will focus on Hormonal and Metabolic Abnormalities in Heart Failure Patients. This issue is one of four selected for the year by the series Consulting Editor, Eduardo Bossone. Topics include, but are not limited to, Glucose metabolism abnormalities in heart failure patients, Diabetic cardiomyopathy, New oral antidiabetics in chronic heart failure, Metabolic syndrome and heart failure, Eritropoietin anemia and iron vs. exercise capacity in chronic heart failure, Prognostic value of hormonal abnormalities in heart failure patients, Hormonal Replacement Therapy in Heart Failure, The management of thyroid abnormalities in chronic heart failure, Acromegaly and heart failure, Beta-receptor signaling and heart failure, and Evaluation of cardiac metabolism by magnetic resonance spectroscopy in heart failure.
The American Heart Association’s Scientific Sessions 2019 is bringing big science, big technology, and big networking opportunities to Philadelphia, Pennsylvania this November. This event features five days of the best in science and cardiovascular clinical practice covering all aspects of basic, clinical, population and translational content.